EUVIMEDEUVIMED entdecken
Crossref

Optogenetically Regulated siRNA Synthesis and Outer Membrane Vesicle-Mediated Delivery by Engineered Bacteria

Long Li, Xin Huang, Xiaoyu Dong, Yanle Wang, Yanning Zhang, Guijie Bai, Yue Jiang, Le Liu, Yinuo Qiu, Zhijie Feng, Peiyuan Liu, Duo Liu und 6 weitere

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.6c00293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Long Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Medicine, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin Uni…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Optogenetics, Escherichia coli, Bacterial Outer Membrane. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hainan Province, Tianjin Natural Science Foundation for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Outer membrane vesicles (OMVs), as promising delivery vectors, have been extensively explored for the delivery of nucleic acid-based drugs, particularly the RNA therapy. However, RNA-loaded OMVs delivery systems derived from in vivo engineered bacteria lack the controllable way for regulating target RNA synthesis. Constitutive RNA synthesis may not only exert excessive metabolic burden on engineered bacteria but also lead to unexpected RNA package and delivery, markedly compromising in vivo biomedical applications. Herein, we developed an optogenetically regulated small interfering RNA (siRNA) synthesis and delivery system based on engineered bacterial OMVs. A proof of concept was demonstrated for combining this optogenetic siRNA delivery system with photothermal therapy (PTT) to evaluate tumor thermal resistance modulation by using dual functional engineered strains. The first strain (opto-siTRPV1@OMVs BL-ves) was designed to secrete siRNA targeting transient receptor potential vanilloid subtype 1 (TRPV1) in response to green light stimulation, while a second melanin-producing strain (BL21-TYR) was established for efficient photothermal ablation under 808 nm near-infrared (NIR) laser irradiation. Experimental results showed that the combined therapeutic regimen demonstrated a preliminary tumor growth inhibition rate of approximately 63.06% in a murine model. Furthermore, this regimen remodeled the immunosuppressive tumor microenvironment (TME), activated antigen-presenting cells, promoted the infiltration of effector T cells, and thereby triggered robust anti-tumor immune responses. This study presents a novel strategy for the precise and regulated delivery of siRNA, and demonstrates the feasibility of optogenetically controlled siRNA production and OMV-mediated delivery in a laboratory setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingOptogeneticsEscherichia coliBacterial Outer MembraneAnimalsMiceTRPV Cation ChannelsPhotothermal TherapyCell Line, Tumor

Stichwörter der Autor:innen

engineered bacteriaoptogenetic regulationouter membrane vesiclesphotothermal therapysiRNA deliverytumor immunotherapy

Substanzen

RNA, Small InterferingTRPV Cation Channels

Autor:innen und Institutionen

  • School of Life Sciences, Faculty of Medicine, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin University, Tianjin300072, China.
  • Tianjin Xinhua Middle School, Tianjin300203, China.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou570228, Chin…
  • Tianjin Savant Biotechnology Co., Tianjin300405, China.
  • Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluatio…
  • Research Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing100191, China.

ORCID-Profile: Peiqi Zhao, Hanjie Wang

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hainan Province
  • Tianjin Natural Science Foundation for Distinguished Young Scholars
  • Beijing Natural Science Foundation of China
  • Tianjin Key Medical Discipline Construction Project
  • Beijing-Tianjin-Hebei Basic Research Cooperation Project of Beijing Natural Science Foundation
  • Shanghai "Pioneer Program" Bio-Hybrid Robot Project;
  • The Open Fund Project of State Key Laboratory of Synthetic Biology

Zitieren

APA

Li, L., Huang, X., Dong, X., Wang, Y., Zhang, Y., Bai, G., Jiang, Y., Liu, L., Qiu, Y., Feng, Z., Liu, P., Liu, D., Lin, S., Hu, C., Zhao, P., Sun, D., Shi, Y., & Wang, H. (2026). Optogenetically Regulated siRNA Synthesis and Outer Membrane Vesicle-Mediated Delivery by Engineered Bacteria. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00293

Vancouver

Li L, Huang X, Dong X, Wang Y, Zhang Y, Bai G, et al. Optogenetically Regulated siRNA Synthesis and Outer Membrane Vesicle-Mediated Delivery by Engineered Bacteria. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00293

BibTeX
@article{Li2026,
  author = {Li, Long and Huang, Xin and Dong, Xiaoyu and Wang, Yanle and Zhang, Yanning and Bai, Guijie and Jiang, Yue and Liu, Le and Qiu, Yinuo and Feng, Zhijie and Liu, Peiyuan and Liu, Duo and Lin, Si and Hu, Chenguang and Zhao, Peiqi and Sun, Dawei and Shi, Yanyan and Wang, Hanjie},
  title = {Optogenetically Regulated siRNA Synthesis and Outer Membrane Vesicle-Mediated Delivery by Engineered Bacteria},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.6c00293}
}
Kostenlos starten →